Skip to main content
. 2002 Apr 8;86(7):1110–1116. doi: 10.1038/sj.bjc.6600231

Figure 1.

Figure 1

Cumulated overall survival rates are shown. In patients <12 months of age, the 2- and 4-year overall survival rates for patients in stages 1, 2A, 2B, 3 and 4S combined (n=437) were 98.8 and 98.5%, respectively, which were significantly higher than the 73.1 and 73.1% for patients in stage 4 (n=43) (P<0.0001). In patients ⩾12 months of age, the 2- and 4-OS rates for patients in 1, 2A, 2B and 3 stages combined (n=53) were 100 and 100%, while those for patients in stage 4 (n=106) were 67.3 and 48.5%, respectively (P<0.0001).